Article Sidebar

Download
PDF

Main Article Content

Abstract

An alkoxy benzamide derivatives are have been synthesized in four steps. Alkylation, halo phenol coupling, nitro group reduction and acid amine coupling gave in decent yield. Likewise, these targets were synthesized by coupling of 4-(3,4-dichlorophenoxy) aniline with N-(4-(3,4-dichlorophenoxy)phenyl)-4-alkoxybenzamide by using (1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexa fluorophosphate, hexa fluorophosphate azabenzotriazole tetramethyl uronium) (HATU), N,N-diisopropylethylamine (DIPEA) in dimethylformamide (DMF) at 0 ºC to room temperature. Reduction of nitro group in the presence of 10% Pd/C, H2 (g) in MeOH at room temperature. Obtained in decent to excellent yield. Anti-tuberculosis activity of all synthesized derivatives (7a-l) was complete against the H37RV strain as per reported broth dilution method mentioned in experimental section. Bio-assay results showing that derivatives 7c, 7e and 7i exhibited exceptional activity against the H37RV strain with MIC value 62.5 μg/mL. Furthermore, other derivatives were showed poor potency against same strain when compared with standard drugs isoniazid and rifampicin.

Keywords

Antibiotics 4-(Octadecyloxy)benzamide Antimicrobial Esters.

Article Details

License

Copyright (c) 2021 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Bhalodiya, P., N. Patel, H., & B. Sangani, C. (2021). Synthesis, Characterization and Biological Activities of N-(4-(3,4-Dichlorophenoxy)-phenyl)-4-alkoxybenzamide Derivatives. Asian Journal of Organic & Medicinal Chemistry, 6(2), 73–78. https://doi.org/10.14233/ajomc.2021.AJOMC-P309
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. W. Vollmer, The Prokaryotic Cytoskeleton: A Putative Target for Inhibitors and Antibiotics?, Appl. Microbiol. Biotechnol., 73, 37 (2006); https://doi.org/10.1007/s00253-006-0586-0
  2. R.L. Lock and E.J. Harry, Cell-Division Inhibitors: New Insights for Future Antibiotics, Nat. Rev. Drug Discov., 7, 324 (2008); https://doi.org/10.1038/nrd2510
  3. F. Janssens, J. Torremans, M. Janssen, R.A. Stokbroekx, M. Luyckx and P.A. Janssen, New Antihistaminic N-heterocyclic 4-Piperidinamines. 1. Synthesis and Antihistaminic Activity of N-(4-Piperidinyl)-1H-benzimidazol-2-amines, J. Med. Chem., 28, 1925 (1985); https://doi.org/10.1021/jm00150a028
  4. L. Dalla Via, O. Gia, S. Marciani Magno, A. Da Settimo, A.M. Marini, G. Primofiore, F. Da Settimo and S. Salerno Synthesis, in vitro Antiproli-ferative Activity and DNA-Interaction of Benzimidazoquinazoline Derivatives as Potential Anti-Tumor Agents, Il Farmaco, 56, 159 (2001); https://doi.org/10.1016/S0014-827X(01)01079-5
  5. R.D. Carpenter, K.S. Lam and M.J. Kurth, Microwave-Mediated Heterocyclization to Benzimidazo[2,1-b]quinazolin-12(5H)-ones, J. Org. Chem., 72, 284 (2007); https://doi.org/10.1021/jo0618066
  6. C.R. Chong, X. Chen, L. Shi, J.O. Liu and D.J. Sullivan Jr., A Clinical Drug Library Screen Identifies Astemizole as an Antimalarial Agent, Nat. Chem. Biol., 2, 415 (2006); https://doi.org/10.1038/nchembio806
  7. D.H. Wright, A.W. Ford-Hutchinson, K. Chadee and K.M. Metters, The Human Prostanoid DP Receptor Stimulates Mucin Secretion in LS174T Cells, Br. J. Pharmacol., 131, 1537 (2000); https://doi.org/10.1038/sj.bjp.0703688
  8. A. Arimura, K. Yasui, J. Kishino, F. Asanuma, H. Hasegawa, S. Kakudo, M. Ohtani and H. Arita, J. Pharmacol. Exp. Ther., 298, 411 (2001).
  9. C. Beaulieu, Z. Wang, D. Denis, G. Greig, S. Lamontagne, G. O’Neill, D. Slipetz and J. Wang, Benzimidazoles as New Potent and Selective DP Antagonists for the Treatment of Allergic Rhinitis, Bioorg. Med. Chem. Lett., 14, 3195 (2004); https://doi.org/10.1016/j.bmcl.2004.04.005
  10. R. Rastogi and S. Sharma, 2-Aminobenzimidazoles in Organic Syntheses, Synthesis, 861 (1983); https://doi.org/10.1055/s-1983-30546
  11. P. Hawkey and D. Lewis, Medical Bacteriology, Oxford University Press: New York (2003).
  12. K.H. Rieckmann, G.H. Campbell, L.J. Sax and J.E. Ema, Drug Sensitivity of Plasmodium falciparum: An in-vitro Microtechnique, Lancet, 311, 22 (1978); https://doi.org/10.1016/S0140-6736(78)90365-3
  13. L.A. Collins and S.G. Franzblau, Microplate Alamar Blue Assay versus BACTEC 460 Aystem for High-Throughput Screening of Compounds against Mycobacterium tuberculosis and Mycobacterium avium, Antimicrob. Agents Chemother., 41, 1004 (1997); https://doi.org/10.1128/AAC.41.5.1004